Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis. [electronic resource]
Producer: 20070326Description: R160 p. digitalISSN:- 1466-609X
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.